![Eran Ovadya](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eran Ovadya
Directeur Financier/CFO chez
NUREXONE BIOLOGIC INC.
Fortune : 692 609 $ au 30/09/2026
Profil
Currently, Eran Ovadya is an Independent Director at Neural Therapeutics, Inc. since 2024 and Chief Financial Officer at NurExone Biologic, Inc. since 2022.
Formerly, Mr. Ovadya was Chief Financial Officer at Forrest Innovations Ltd., Cannibble Foodtech Ltd., and V.V.T.
Med Ltd. from 2017 to 2021, and Chief Financial Officer at Silexion Therapeutics Ltd. and ProCore Biomed Ltd. from 2020 to 2021.
Education includes undergraduate and MBA degrees from The Open University of Israel.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUREXONE BIOLOGIC INC 1,63 % | 27/11/2025 | 1 575 000 ( 1,63 % ) | 680 400 $ | 30/09/2026 |
NEURAL THERAPEUTICS INC. 0,48 % | 14/04/2026 | 813 929 ( 0,48 % ) | 12 209 $ | 31/07/2026 |
Postes actifs de Eran Ovadya
| Sociétés | Poste | Début |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Directeur Financier/CFO | 15/06/2022 |
| NEURAL THERAPEUTICS INC. | Directeur/Membre du Conseil | 13/12/2024 |
Anciens postes connus de Eran Ovadya
| Sociétés | Poste | Fin |
|---|---|---|
Forrest Innovations Ltd.
 Forrest Innovations Ltd. Internet Software/ServicesTechnology Services Operates biological platform to help get rid of mosquito-borne diseases | Directeur Financier/CFO | 01/05/2021 |
| ULTROBOTIX LTD. | Directeur Financier/CFO | 01/05/2021 |
Silexion Therapeutics Ltd.
 Silexion Therapeutics Ltd. BiotechnologyHealth Technology Operates as aa clinical-stage oncology-focused biotechnology company | Directeur Financier/CFO | 01/04/2021 |
V.V.T. Med Ltd.
 V.V.T. Med Ltd. Medical SpecialtiesHealth Technology Manufactures vein treatment devices | Directeur Financier/CFO | 01/04/2021 |
Formation de Eran Ovadya
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
The Open University of Israel
 The Open University of Israel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. BiotechnologyHealth Technology Operates as aa clinical-stage oncology-focused biotechnology company | Health Technology |
V.V.T. Med Ltd.
V.V.T. Med Ltd. Medical SpecialtiesHealth Technology Manufactures vein treatment devices | Health Technology |
Forrest Innovations Ltd.
Forrest Innovations Ltd. Internet Software/ServicesTechnology Services Operates biological platform to help get rid of mosquito-borne diseases | Technology Services |
Neural Therapeutics, Inc.
 Neural Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Operates as an ethnobotanical drug discovery and development company that focuses on developing products and conducting research with psychoactive plants | Health Technology |
Cannibble Foodtech Ltd.
 Cannibble Foodtech Ltd. Beverages: Non-AlcoholicConsumer Non-Durables Manufactures premixed foods, beverages, nutritional supplements and spices | Consumer Non-Durables |
NurExone Biologic, Inc.
 NurExone Biologic, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Health Technology |
